3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Squamous Cell Carcinoma of Head and Neck
8
Head and Neck Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Triple Negative Breast Neoplasms
3
Stomach Neoplasms
3
Ovarian Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Spinocerebellar Degenerations
1
Small Cell Lung Carcinoma
1
Peritoneal Neoplasms
1
Nasopharyngeal Neoplasms
1
Nasopharyngeal Carcinoma
1
Mesothelioma, Malignant
1
Glioma
1
Fallopian Tube Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Carcinoma, Pancreatic Ductal
1
Interventions
pembrolizumab
30
Nivolumab
10
Cyclophosphamide
9
fludarabine
7
atezolizumab
7
aldesleukin
5
Paclitaxel
5
Magnetic Resonance Spectroscopy
5
Ipilimumab
5
Carboplatin
5
Biopsy
5
cemiplimab
4
Trastuzumab
4
Interleukin-2
4
Docetaxel
4
Cisplatin
4
spartalizumab
3
durvalumab
3
Specimen Handling
3
Polymerase Chain Reaction
3
Gene Expression Profiling
3
Fulvestrant
3
Fluorouracil
3
tisotumab vedotin
2
tislelizumab
2
palbociclib
2
fludarabine phosphate
2
entinostat
2
avelumab
2
X-Rays
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Cervical Neoplasms
×
Leucovorin
×
Head & Neck
×
Clear all
NCT05891171
2026-03-31
ARC-25
Arcus Biosciences, Inc.
Phase 1
Active not recruiting
40 enrolled